Assessing acute colitis induced by dextran sulfate sodium in rats and its impact on gastrointestinal fluids
暂无分享,去创建一个
T. Rades | A. Müllertz | R. Berthelsen | M. Klitgaard | J. Jacobsen | P. Guerra | M. N. Kristensen | R. Venkatasubramanian
[1] Y. Lim,et al. Oxyresveratrol Ameliorates Dextran Sulfate Sodium-Induced Colitis in Rats by Suppressing Inflammation , 2021, Molecules.
[2] Jiande D. Z. Chen,et al. Transitional changes in gastrointestinal transit and rectal sensitivity from active to recovery of inflammation in a rodent model of colitis , 2021, Scientific Reports.
[3] A. Stallmach,et al. An Update for Pharmacologists on New Treatment Options for Inflammatory Bowel Disease: The Clinicians’ Perspective , 2021, Frontiers in Pharmacology.
[4] A. Day,et al. An Overview of Tools to Score Severity in Pediatric Inflammatory Bowel Disease , 2021, Frontiers in Pediatrics.
[5] Christel A. S. Bergström,et al. Proteomics-informed identification of luminal targets for in situ diagnosis of inflammatory bowel disease. , 2020, Journal of pharmaceutical sciences.
[6] H. Itoh,et al. Circulating S100A8/A9 is potentially a biomarker that could reflect the severity of experimental colitis in rats , 2020, Heliyon.
[7] L. Stassen,et al. ECCO Guidelines on Therapeutics in Crohn's Disease: medical treatment. , 2019, Journal of Crohn's & colitis.
[8] Mohamed A. K. Basuony,et al. Telmisartan ameliorates dextran sodium sulfate-induced colitis in rats by modulating NF-κB signalling in the context of PPARγ agonistic activity. , 2019, Archives of biochemistry and biophysics.
[9] A. Müllertz,et al. Developing a predictive in vitro dissolution model based on gastrointestinal fluid characterisation in rats. , 2019, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[10] J. Frank,et al. Therapeutic ultrasound attenuates DSS-induced colitis through the cholinergic anti-inflammatory pathway , 2019, EBioMedicine.
[11] S. Vermeire,et al. New biologics and small molecules in inflammatory bowel disease: an update , 2019, Therapeutic advances in gastroenterology.
[12] S. Devaraj,et al. Anti-inflammatory activity of Alpinia officinarum hance on rat colon inflammation and tissue damage in DSS induced acute and chronic colitis models , 2018, Food Science and Human Wellness.
[13] T. Tomita,et al. Association between gastrointestinal motility and macrophage/mast cell distribution in mice during the healing stage after DSS-induced colitis , 2018, Molecular medicine reports.
[14] K. Katsanos,et al. Role of bile acids in inflammatory bowel disease , 2018, Annals of gastroenterology.
[15] Kung-I Feng,et al. Effect of composition of simulated intestinal media on the solubility of poorly soluble compounds investigated by design of experiments , 2018, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[16] C. Lehr,et al. Targeted delivery of Cyclosporine A by polymeric nanocarriers improves the therapy of inflammatory bowel disease in a relevant mouse model , 2017, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[17] K. Kharbanda,et al. Dextran sodium sulfate colitis murine model: An indispensable tool for advancing our understanding of inflammatory bowel diseases pathogenesis , 2017, World journal of gastroenterology.
[18] C. Langner,et al. Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders. , 2017, Journal of Crohn's & colitis.
[19] H. Tilg,et al. Lipocalin-2: A Master Mediator of Intestinal and Metabolic Inflammation , 2017, Trends in Endocrinology & Metabolism.
[20] T. Molnár,et al. Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management. , 2017, Journal of Crohn's & colitis.
[21] A Müllertz,et al. In Vivo Precipitation of Poorly Soluble Drugs from Lipid-Based Drug Delivery Systems. , 2016, Molecular pharmaceutics.
[22] P. Blier,et al. MAG-EPA reduces severity of DSS-induced colitis in rats. , 2016, American journal of physiology. Gastrointestinal and liver physiology.
[23] J. Clarke,et al. Housing experimental rats in solid-based cages with digestible bedding may confound outcomes of nutritional studies. , 2015, Journal of the science of food and agriculture.
[24] J. Dressman,et al. Composition and physicochemical properties of fasted-state human duodenal and jejunal fluid: a critical evaluation of the available data. , 2014, Journal of pharmaceutical sciences.
[25] A. Müllertz,et al. Toward the Establishment of Standardized In Vitro Tests for Lipid-Based Formulations, Part 6: Effects of Varying Pancreatin and Calcium Levels , 2014, The AAPS Journal.
[26] C. Pouton,et al. An in vitro digestion test that reflects rat intestinal conditions to probe the importance of formulation digestion vs first pass metabolism in Danazol bioavailability from lipid based formulations. , 2014, Molecular pharmaceutics.
[27] Mark McAllister,et al. Early pharmaceutical profiling to predict oral drug absorption: current status and unmet needs. , 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[28] B. Chassaing,et al. Dextran Sulfate Sodium (DSS)‐Induced Colitis in Mice , 2014, Current protocols in immunology.
[29] V. Préat,et al. Budesonide-loaded nanostructured lipid carriers reduce inflammation in murine DSS-induced colitis. , 2013, International journal of pharmaceutics.
[30] A. Müllertz,et al. Bile salts and their importance for drug absorption. , 2013, International journal of pharmaceutics.
[31] Shyamasree Ghosh,et al. C-reactive protein and the biology of disease , 2013, Immunologic Research.
[32] A. Young,et al. Fecal Lipocalin 2, a Sensitive and Broadly Dynamic Non-Invasive Biomarker for Intestinal Inflammation , 2012, PloS one.
[33] Yutao Yan,et al. Dextran Sodium Sulfate (DSS) Induces Colitis in Mice by Forming Nano-Lipocomplexes with Medium-Chain-Length Fatty Acids in the Colon , 2012, PloS one.
[34] J. Lewis. The utility of biomarkers in the diagnosis and therapy of inflammatory bowel disease. , 2011, Gastroenterology.
[35] I. Cuthill,et al. Animal Research: Reporting In Vivo Experiments: The ARRIVE Guidelines , 2010, British journal of pharmacology.
[36] J. Dressman,et al. Characterization of the Ascending Colon Fluids in Ulcerative Colitis , 2010, Pharmaceutical Research.
[37] G. Dalmasso,et al. Drug-loaded nanoparticles targeted to the colon with polysaccharide hydrogel reduce colitis in a mouse model. , 2010, Gastroenterology.
[38] T. Langmann,et al. Serum bile acid profiling reflects enterohepatic detoxification state and intestinal barrier function in inflammatory bowel disease. , 2009, World journal of gastroenterology.
[39] Christos Reppas,et al. Characterization of the Contents of Ascending Colon to Which Drugs are Exposed After Oral Administration to Healthy Adults , 2009, Pharmaceutical Research.
[40] H. Takeuchi,et al. pH-Sensitive nanospheres for colon-specific drug delivery in experimentally induced colitis rat model. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[41] M. Geier,et al. Small-Intestinal Manifestations of Dextran Sulfate Sodium Consumption in Rats and Assessment of the Effects of Lactobacillus fermentum BR11 , 2009, Digestive Diseases and Sciences.
[42] J. Jahnsen,et al. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study , 2008, Gut.
[43] W. Koltun,et al. Loss of the tight junction protein ZO-1 in dextran sulfate sodium induced colitis. , 2007, The Journal of surgical research.
[44] Stefan Wirtz,et al. Chemically induced mouse models of intestinal inflammation , 2007, Nature Protocols.
[45] Makoto Kataoka,et al. Site of drug absorption after oral administration: assessment of membrane permeability and luminal concentration of drugs in each segment of gastrointestinal tract. , 2006, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[46] Takuji Tanaka,et al. Dextran sodium sulfate strongly promotes colorectal carcinogenesis in ApcMin/+ mice: Inflammatory stimuli by dextran sodium sulfate results in development of multiple colonic neoplasms , 2006, International journal of cancer.
[47] K. Hatakeyama,et al. Multipotential acceptance of Peyer's patches in the intestine for both thymus‐derived T cells and extrathymic T cells in mice , 2005, Immunology and cell biology.
[48] Y. Kawashima,et al. A pH-sensitive microsphere system for the colon delivery of tacrolimus containing nanoparticles. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[49] S. Poulsen,et al. Luminal and parenteral TFF2 and TFF3 dimer and monomer in two models of experimental colitis in the rat , 2005, Regulatory Peptides.
[50] C. Hack,et al. Rat C‐reactive protein activates the autologous complement system , 2003, Immunology.
[51] M. Grisham,et al. Role of appendix and spleen in experimental colitis. , 2001, The Journal of surgical research.
[52] D. Rampton,et al. Intestinal luminal pH in inflammatory bowel disease: possible determinants and implications for therapy with aminosalicylates and other drugs , 2001, Gut.
[53] R. Verger,et al. The specific activities of human digestive lipases measured from the in vivo and in vitro lipolysis of test meals. , 2000, Gastroenterology.
[54] Press,et al. Gastrointestinal pH profiles in patients with inflammatory bowel disease , 1998, Alimentary pharmacology & therapeutics.
[55] C. Elson,et al. Experimental models of inflammatory bowel disease. , 1995, Gastroenterology.
[56] R. Gore. Colonic contour changes in chronic ulcerative colitis: reappraisal of some old concepts. , 1992, AJR. American journal of roentgenology.
[57] M. Hamosh,et al. Lingual and gastric lipases: species differences in the origin of prepancreatic digestive lipases and in the localization of gastric lipase. , 1988, Biochimica et biophysica acta.
[58] M. Coates,et al. Gastrointestinal pH measurement in rats: influence of the microbial flora, diet and fasting , 1987, Laboratory animals.
[59] J. Tanner,et al. Standards from birth to maturity for height, weight, height velocity, and weight velocity: British children, 1965. I. , 1966, Archives of disease in childhood.
[60] H. Smith,et al. OBSERVATIONS ON THE FLORA OF THE ALIMENTARY TRACT OF ANIMALS AND FACTORS AFFECTING ITS COMPOSITION. , 1965, The Journal of pathology and bacteriology.